10-Q Filing

PFIZER INC CIK: 78003 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000078003-21-000093`
Period End Date	20210630
Filing Date	20210812
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	pfe-20210704_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 92 Cash Flow Statement 94 Stockholders Equity 52 Comprehensive Income 68

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$500.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$508.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.37B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$14.81B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.33B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.00B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$10.44B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$19.33B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.69B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$500; 2020$508	`AccountsReceivableNetCurrent`	$7.93B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$500; 2020$508	`AccountsReceivableNetCurrent`	$10.59B	USD	Point-in-time
Inventories	`InventoryNet`	$8.05B	USD	Point-in-time
Inventories	`InventoryNet`	$8.95B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.76B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.26B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.82B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.60B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$35.07B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$48.81B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.86B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.61B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$3.41B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$4.33B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2021$15,328; 2020$14,812	`PropertyPlantAndEquipmentNet`	$14.22B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2021$15,328; 2020$14,812	`PropertyPlantAndEquipmentNet`	$13.90B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$28.47B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.32B	USD	Point-in-time
Goodwill	`Goodwill`	$49.87B	USD	Point-in-time
Goodwill	`Goodwill`	$49.58B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$2.69B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$2.38B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$6.06B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$4.57B	USD	Point-in-time
Total assets	`Assets`	$154.23B	USD	Point-in-time
Total assets	`Assets`	$169.92B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$3,687; 2020$2,002	`DebtCurrent`	$3.89B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$3,687; 2020$2,002	`DebtCurrent`	$2.70B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.33B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.31B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.18B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.16B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.74B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.05B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$2.02B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.06B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$1.11B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$4.29B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.22B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$11.53B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.92B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.66B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$37.13B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$35.35B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$4.77B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$4.30B	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$634.00M	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$645.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$4.16B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$4.06B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.56B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.26B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$6.67B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$8.23B	USD	Point-in-time
Total liabilities	`Liabilities`	$90.76B	USD	Point-in-time
Total liabilities	`Liabilities`	$99.61B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$472.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$470.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$89.34B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.67B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$111.36B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$110.99B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$96.35B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$90.39B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.76B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$63.24B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$70.04B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$273.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$235.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.34B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.86B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$169.92B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$154.23B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$18.98B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$19.95B	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$33.56B	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$9.86B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$7.05B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$3.77B	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.83B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$11.26B	USD	2 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.93B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$5.71B	USD	2 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$5.20B	USD	2 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.66B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.08B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.46B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.75B	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.47B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$931.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$869.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$1.80B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$1.72B	USD	2 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$-1.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$22.00M	USD	2 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$360.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$414.00M	USD	2 Qtrs
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	2 Qtrs
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	$6.00M	USD	2 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$764.00M	USD	2 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$998.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$2.00B	USD	2 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$955.00M	USD	1 Quarter
Income from continuing operations before provision for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.87B	USD	2 Qtrs
Income from continuing operations before provision for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.61B	USD	1 Quarter
Income from continuing operations before provision for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.03B	USD	1 Quarter
Income from continuing operations before provision for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$12.29B	USD	2 Qtrs
Provision for taxes on income	`IncomeTaxExpenseBenefit`	$1.85B	USD	2 Qtrs
Provision for taxes on income	`IncomeTaxExpenseBenefit`	$1.04B	USD	1 Quarter
Provision for taxes on income	`IncomeTaxExpenseBenefit`	$422.00M	USD	1 Quarter
Provision for taxes on income	`IncomeTaxExpenseBenefit`	$782.00M	USD	2 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.57B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.09B	USD	2 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$2.60B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$10.44B	USD	2 Qtrs
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$893.00M	USD	1 Quarter
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$32.00M	USD	2 Qtrs
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$24.00M	USD	1 Quarter
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.77B	USD	2 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$10.47B	USD	2 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.59B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$3.50B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$6.86B	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$17.00M	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$26.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$35.00M	USD	2 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$3.49B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$6.84B	USD	2 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$5.56B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$10.44B	USD	2 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.47	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.91	USD	2 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.86	USD	2 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.99	USD	1 Quarter
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.32	USD	2 Qtrs
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.16	USD	1 Quarter
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.01	USD	2 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.99	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.87	USD	2 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.23	USD	2 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.90	USD	2 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.98	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.46	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.84	USD	2 Qtrs
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.16	USD	1 Quarter
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.01	USD	2 Qtrs
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.32	USD	2 Qtrs
Income from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.98	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.62	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.22	USD	2 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.84	USD	2 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.60B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.55B	shares	2 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.55B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.59B	shares	2 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.62B	shares	2 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.68B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.67B	shares	2 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.62B	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$10.47B	USD	2 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.59B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$3.50B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$6.86B	USD	2 Qtrs
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.77B	USD	2 Qtrs
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$24.00M	USD	1 Quarter
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$32.00M	USD	2 Qtrs
Income from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$893.00M	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$10.44B	USD	2 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.57B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.09B	USD	2 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$2.60B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$2.37B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$2.55B	USD	2 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$58.00M	USD	2 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$77.00M	USD	2 Qtrs
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	-	USD	2 Qtrs
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$6.00M	USD	2 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$33.00M	USD	2 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$47.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$244.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$394.00M	USD	2 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$779.00M	USD	2 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$526.00M	USD	2 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$1.30B	USD	2 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$370.00M	USD	2 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$2.06B	USD	2 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$-4.40B	USD	2 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$15.83B	USD	2 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$4.83B	USD	2 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$1.86B	USD	2 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$9.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$15.84B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.69B	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.09B	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$906.00M	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$15.98B	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$5.14B	USD	2 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$7.57B	USD	2 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$4.59B	USD	2 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$537.00M	USD	2 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$505.00M	USD	2 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$168.00M	USD	2 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$100.00M	USD	2 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$536.00M	USD	2 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$297.00M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$9.00M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$72.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.63B	USD	2 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.88B	USD	2 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-11.45B	USD	2 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.88B	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.08B	USD	2 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	-	USD	2 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$12.35B	USD	2 Qtrs
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$13.17B	USD	2 Qtrs
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-499.00M	USD	2 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-2.31B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.19B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$2.18B	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$4.22B	USD	2 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$4.36B	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-509.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-163.00M	USD	2 Qtrs
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-4.49B	USD	2 Qtrs
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-5.36B	USD	2 Qtrs
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$11.45B	USD	2 Qtrs
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.96B	USD	2 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.36B	USD	2 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-70.00M	USD	2 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.00M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$593.00M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$495.00M	USD	2 Qtrs
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.84B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.42B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.42B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.84B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$2.19B	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	$1.29B	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$910.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$798.00M	USD	2 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$-66.00M	USD	2 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$-67.00M	USD	2 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$74.00M	USD	2 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.20B	USD	2 Qtrs

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.76	USD	2 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.78	USD	2 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.76	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.78	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.34B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.86B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Net income	`ProfitLoss`	$6.86B	USD	2 Qtrs
Net income	`ProfitLoss`	$3.50B	USD	1 Quarter
Net income	`ProfitLoss`	$5.59B	USD	1 Quarter
Net income	`ProfitLoss`	$10.47B	USD	2 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.63B	USD	2 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-92.00M	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$556.00M	USD	2 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-187.00M	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$4.38B	USD	2 Qtrs
Common stock	`DividendsCommonStockCash`	$4.29B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$4.29B	USD	2 Qtrs
Common stock	`DividendsCommonStockCash`	$4.22B	USD	1 Quarter
Preferred stock	`DividendsPreferredStockCash`	-	USD	1 Quarter
Preferred stock	`DividendsPreferredStockCash`	-	USD	2 Qtrs
Preferred stock	`DividendsPreferredStockCash`	-	USD	2 Qtrs
Preferred stock	`DividendsPreferredStockCash`	-	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$80.00M	USD	2 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	2 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$80.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$222.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$266.00M	USD	2 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$251.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$221.00M	USD	2 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	2 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	2 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	$1.00M	USD	2 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	2 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	1 Quarter
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	2 Qtrs
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$6.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$33.00M	USD	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.86B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.34B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time

Comprehensive Income 68 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$10.47B	USD	2 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.59B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$3.50B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$6.86B	USD	2 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-173.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$501.00M	USD	2 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-1.43B	USD	2 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$36.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$213.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-35.00M	USD	2 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-288.00M	USD	2 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-248.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-238.00M	USD	2 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$21.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$167.00M	USD	2 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$186.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-270.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-455.00M	USD	2 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$203.00M	USD	2 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$27.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-9.00M	USD	2 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$138.00M	USD	2 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$59.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$42.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-61.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$181.00M	USD	2 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-59.00M	USD	2 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$120.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$50.00M	USD	2 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$87.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-43.00M	USD	2 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-89.00M	USD	2 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-45.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-39.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-79.00M	USD	2 Qtrs
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$1.00M	USD	1 Quarter
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$-4.00M	USD	2 Qtrs
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$5.00M	USD	2 Qtrs
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$-5.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$84.00M	USD	2 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$85.00M	USD	2 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$41.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$40.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-100.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-155.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-1.92B	USD	2 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$577.00M	USD	2 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-63.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$87.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$21.00M	USD	2 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-293.00M	USD	2 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-1.63B	USD	2 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-92.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$556.00M	USD	2 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-187.00M	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.31B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.50B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$11.03B	USD	2 Qtrs
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.23B	USD	2 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$38.00M	USD	2 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$28.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-4.00M	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$5.47B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$10.99B	USD	2 Qtrs
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$3.31B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$5.23B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.